Inovio Pharmaceuticals, Inc. (INO) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to…
Source: Yahoo Finance
Sector & Industry
Inovio Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Inovio Pharmaceuticals, Inc. at a Glance
| Company | Inovio Pharmaceuticals, Inc. |
| Ticker | INO |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $1.43 |
| Market cap | $147.86M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.03 |
| 52-week high | $2.98 |
| 52-week low | $0.56 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.63 |
| Return on equity (ROE) | -409.87% |
| Debt-to-equity | 183.07% |
| Average volume | 3.45M |
| Shares outstanding | 103.40M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 112 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Inovio Pharmaceuticals, Inc.'s current P/E ratio?
- Inovio Pharmaceuticals, Inc. (INO) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Inovio Pharmaceuticals, Inc.'s market capitalisation?
- Inovio Pharmaceuticals, Inc.'s market cap is $147.86M based on our latest snapshot. See how it ranks by market cap →
- What is INO's 52-week range?
- Over the past 52 weeks, INO has traded between $0.56 and $2.98. What does the 52-week range mean? →
- How volatile is Inovio Pharmaceuticals, Inc. compared to the market?
- Inovio Pharmaceuticals, Inc. has a beta of 1.63, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Inovio Pharmaceuticals, Inc. pay a dividend?
- Inovio Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is INO listed on?
- INO is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Inovio Pharmaceuticals, Inc. in?
- Inovio Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →